Patents by Inventor Alison Gillespie

Alison Gillespie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human calcium channel compositions and methods
    Patent number: 7414110
    Abstract: Isolated DNA encoding each of human calcium channel ?1-, ?2-, ?- and ?-subunits, including subunits that arise as splice variants of primary transcripts, is provided. Cells and vectors containing the DNA and methods for identifying compounds that modulate the activity of human calcium channels are also provided.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: August 19, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Michael M. Harpold, Steven B. Ellis, Mark E. Williams, Ann F. McCue, Alison Gillespie, Daniel H. Feldman, Robert Brenner
  • Human calcium channel compositions and methods
    Publication number: 20070244297
    Abstract: Isolated DNA encoding each of human calcium channel ?1-, ?2-, ?- and ?-subunits, including subunits that arise as splice variants of primary transcripts, is provided. Cells and vectors containing the DNA and methods for identifying compounds that modulate the activity of human calcium channels are also provided.
    Type: Application
    Filed: February 5, 2007
    Publication date: October 18, 2007
    Inventors: Michael Harpold, Steven Ellis, Mark Williams, Ann McCue, Alison Gillespie, Daniel Feldman, Robert Brenner
  • DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor
    Publication number: 20050287663
    Abstract: Isolated nucleic acid molecules, i.e., DNA or RNA encoding human neuronal nicotinic acetylcholine receptor ? and ? subunits, mammalian and amphibian cells containing said DNA, methods for producing ? and ? subunits and recombinant (i.e., isolated or substantially pure) ? subunits and ? subunits are provided. In addition, cells expressing various multimeric combinations of subunits (i.e., ?1, ?2 ?3 ?4 ?5 ?6 and/or ?7 in combination with at least one of an ? and ? subunit are also provided. A recombinant, non-human cell line expressing the human ?7 subunit of nAChR is also disclosed.
    Type: Application
    Filed: May 4, 2005
    Publication date: December 29, 2005
    Inventors: Alison Gillespie, Brian Claeps, Laura Chavez-Noriega, Robert Siegel, Kathryn Elliott
  • Human calcium channel compositions and methods
    Publication number: 20040018510
    Abstract: Isolated DNA encoding each of human calcium channel &agr;1-, &agr;2-, &bgr;- and &ggr;-subunits, including subunits that arise as splice variants of primary transcripts, is provided. Cells and vectors containing the DNA and methods for identifying compounds that modulate the activity of human calcium channels are also provided.
    Type: Application
    Filed: February 27, 2003
    Publication date: January 29, 2004
    Applicant: Merck & Co., Inc.
    Inventors: Michael M. Harpold, Steven B. Ellis, Mark E. Williams, Ann F. McCue, Alison Gillespie, Daniel H. Feldman, Robert Brenner
  • Human calcium channel compositions and methods
    Patent number: 6653097
    Abstract: Isolated DNA encoding each of human calcium channel &agr;1-, &agr;2-, &bgr;- and &ggr;-subunits, including subunits that arise as splice variants of primary transcripts, is provided. Cells and vectors containing the DNA and methods for identifying compounds that modulate the activity of human calcium channels are also provided.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: November 25, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Michael M. Harpold, Steven B. Ellis, Mark E. Williams, Ann F. McCue, Alison Gillespie, Daniel H. Feldman, Robert Brenner